The cytotoxicity of novel acridine-based N-acyl-homoserine lactone (AHL) analogs was investigated on the human oral squamous carcinoma cell line SAS. One analog induced G2/M phase arrest at 5.3-10.6 μM and induced polyploidy at a higher dose (21.2 μM). Importantly, treatment of SAS cells with a combination of the AHL analog and the Jun N-terminal kinase (JNK) inhibitor, SP600125, prevented mitosis and induced polyploidy. The AHL analog synergized with X-irradiation to inhibit clonogenic survival of SAS cells; however, its radiosensitizing effects were relative to not X-irradiation-induced apoptosis but mitotic failure following enhanced expression of Aurora A and B. These results suggest that the active AHL analog showed growth-suppressive and radiosensitizing effects, which involve polyploidy followed by G2/M accumulation and atypical cell death in the SAS cell line. © 2012 The Pharmaceutical Society of Japan.
CITATION STYLE
Chai, H., Hazawa, M., Hosokawa, Y., Igarashi, J., Suga, H., & Kashiwakura, I. (2012). Novel acridine-based N-acyl-homoserine lactone analogs induce endoreduplication in the human oral squamous carcinoma cell line SAS. Biological and Pharmaceutical Bulletin, 35(8), 1257–1263. https://doi.org/10.1248/bpb.b12-00033
Mendeley helps you to discover research relevant for your work.